Assessing symptom burden using the M. D. Anderson Symptom Inventory in patients with chemotherapy-induced anemia: Results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-α at a dose of 200 μg every 2 weeks

Janice L. Gabrilove, Edith A. Perez, Dianne K. Tomita, Greg Rossi, Charles S. Cleeland

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Assessing symptom burden using the M. D. Anderson Symptom Inventory in patients with chemotherapy-induced anemia: Results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-α at a dose of 200 μg every 2 weeks'. Together they form a unique fingerprint.

Medicine & Life Sciences